FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/21/2026

1. BA
2. SPY
3. RTX
4. USO
5. AMC
6. NVDA
7. XFLT
8. GE
9. DPZ
10. EVEX

Go back to FDA Approves EYLEA® (aflibercept) Injection for Diabetic Retinopathy
Regeneron (NASDAQ: REGN) Delayed: 672.15 -4.54 (0.67%)
Previous Close $676.69    52 Week High $592.36 
Open $674.72    52 Week Low $325.35 
Day High $681.74    P/E 176.42 
Day Low $669.88    EPS $3.81 
Volume 624,791